(Q52036286)

20 April 2018

title

Prevalence of psychiatric disorders in patients with irritable bowel syndrome. (English)

1 reference

20 April 2018

0 references

Lydiard RB

1

1 reference

20 April 2018

Fossey MD

series ordinal

2

1 reference

20 April 2018

Marsh W

series ordinal

3

1 reference

20 April 2018

Ballenger JC

series ordinal

4

1 reference

20 April 2018

publication date

1 May 1993

1 reference

20 April 2018

published in

Psychosomatics

1 reference

20 April 2018

volume

34

1 reference

20 April 2018

page(s)

229-234

1 reference

20 April 2018

issue

3

1 reference

20 April 2018

Variation of bowel habit in two population samples

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971884-8

7 January 2021

Irritable bowel syndrome and psychiatric illness

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971884-8

7 January 2021

Psychological significance of the irritable colon syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971884-8

7 January 2021

Large bowel disorders. II. Psychopathology and alexithymia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971884-8

7 January 2021

Prevalence of attention deficit disorder, residual type, and other psychiatric disorders in patients with irritable colon syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971884-8

7 January 2021

Life events, psychiatric illness and the irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971884-8

7 January 2021

Psychiatric illness and irritable bowel syndrome: a comparison with inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971884-8

7 January 2021

The role of anxiety and depression in the irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971884-8

7 January 2021

The functioning and well-being of depressed patients. Results from the Medical Outcomes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971884-8

7 January 2021

Medical comorbidity of major depressive disorder in a primary medical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971884-8

7 January 2021

Reduction of gastrointestinal symptoms following treatment for panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971884-8

7 January 2021

Controlled treatment trials in the irritable bowel syndrome: a critique.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971884-8

7 January 2021

Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971884-8

7 January 2021

Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971884-8

7 January 2021

Locus coeruleus neurons and sympathetic nerves: activation by visceral afferents

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971884-8

7 January 2021

Fear and anxiety: relationship to noradrenergic function

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2893%2971884-8

7 January 2021

10.1016/S0033-3182(93)71884-8

Identifiers

DOI

1 reference

20 April 2018

PubMed ID

8493304

1 reference

20 April 2018